1 / 7

Penile Cancer Treatment Market 10-Year Forecast

Penile cancer is a disease in which cancerous cells forms into tissues of the penis, a male sex organ which helps body to pass sperms and excrete urine from body. Penile cancers is generally caused by body fluid that gets entangled into the skin. If these body fluids are not washed off on regular basis, it may produce cancer-causing effects. Acquired immune deficiency syndrome (AIDS) and human papilloma virus (HPV) are the most common viruses that cause penile cancer. Other causes include frequent tobacco use, poor hygiene, and other skin diseases. Smokers and older men are more prone to suffer from penile cancer. Signs and symptoms of penile cancer include bleeding, lumps, redness, sores among others. According to United Nations Programme on HIV/AIDS (UNAIDS), 15.5 Mn patients are on antiretroviral therapy (as of June 2015), 36.9 Mn people globally were living with HIV (as of December 2014), 2 Mn patients became newly infected with HIV (as of December 2014), and 1.2 Mn people died from AIDS-related illness (as of December 2014). This has encouraged pharmaceutical companies to invest in penile cancer treatment market and develop drugs for penile cancer.

Ethan_smith
Télécharger la présentation

Penile Cancer Treatment Market 10-Year Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Penile Cancer Treatment Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2016 Future Market Insights www.futuremarketinsights.com sales@futuremarketinsights.com

  2. Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Subscription Information Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Customized Research Syndicated Research Investment Research Social Media Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

  3. Report Description Report Description Penile cancer is a disease in which cancerous cells forms into tissues of the penis, a male sex organ which helps body to pass sperms and excrete urine from body. Penile cancers is generally caused by body fluid that gets entangled into the skin. If these body fluids are not washed off on regular basis, it may produce cancer-causing effects. Acquired immune deficiency syndrome (AIDS) and human papilloma virus (HPV) are the most common viruses that cause penile cancer. Other causes include frequent tobacco use, poor hygiene, and other skin diseases. Smokers and older men are more prone to suffer from penile cancer. Signs and symptoms of penile cancer include bleeding, lumps, redness, sores among others. According to United Nations Programme on HIV/AIDS (UNAIDS), 15.5 Mn patients are on antiretroviral therapy (as of June 2015), 36.9 Mn people globally were living with HIV (as of December 2014), 2 Mn patients became newly infected with HIV (as of December 2014), and 1.2 Mn people died from AIDS-related illness (as of December 2014). This has encouraged pharmaceutical companies to invest in penile cancer treatment market and develop drugs for penile cancer. Penile Cancer Treatment Market: Drivers and Restraints Increasing incidence of penile cancer is a major driver for the growth of global penile cancer treatment market. Advancement in technology coupled with personalized medicine, and cost effective treatment procedures for penile cancer will drive penile cancer market across the globe. However, lack of inadequate reimbursement policies, healthcare literacy, and commercially less availability of drugs for the treatment of penile cancer are the factors which will hamper the growth of global penile cancer treatment market over the forecasted period.

  4. Report Description Report Description Request Free Report Sample@http://www.futuremarketinsights.com/reports/sample/rep-gb-1462 Penile Cancer Treatment Market: Segmentation The global penile cancer treatment market is segmented based on type of disease, therapy and diagnostic test. Based on type of disease, the global penile cancer treatment market is segmented into the following: Squamous cell cancer of penis Adenocarcinoma of penis Melanoma of the penis Basal cell cancer of penis Sarcoma of penis Based on type of therapy, the global penile cancer market is segmented into the following: Radiation Therapy Chemotherapy Biological Therapy

  5. Report Description Report Description Based on type of diagnostic test, the global penile cancer market is segmented into the following: Biopsy Ultrasound Imaging tests Computed Tomography (CT) Position Emission Tomography (PET) Magnetic Resonance Imaging (MRI) Request For TOC@http://www.futuremarketinsights.com/toc/rep-gb-1462 Penile Cancer Treatment Market: Market Overview Research studies conducted by American Cancer Society has shown that patients suffering with squamous cell cancer of penis, the most common penile malignancy, acts similarly to squamous cell cancer of other parts of body. Surgery is the most preferred way of treatment for penile cancer. Radiation therapy can be prescribed instead of surgery if cancer has spread to the bones. Radiation therapy segment is expected to be the highest revenue generating in terms of therapy type segmentation. Chemotherapy is prescribed for some larger tumors or if the cancer has spread to other parts of body extensively. MRI is a best way to understand exact picture of penile cancerous cells.

  6. Report Description Report Description MRI followed by CT scan is generally performed at initial stage of diagnosis of penile cancer. PET is comparatively new technique which is performed for screening the biological activity of tumor. Biopsy should be performed in patients suffering with penile cancer with lesions. Penile Cancer Treatment Market: Region-wise Outlook Geographically, global breast biopsy device market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, Middle East and Africa (MEA). APEJ followed by MEA dominates global penile cancer treatment market owing to large pool of patient suffering with HIV, and increasing awareness about penile cancer. Thus, penile cancer treatment market in APEJ and MEA are expected to grow with significant CAGR over the forecasted period. However penile cancer incidences are rare in North America and Europe. According to American Cancer Society, penile cancer occurs in less than one man in 100, 000 and accounts for less than 1% of cancers in men in the U.S. Ask The Analyst@http://www.futuremarketinsights.com/askus/rep-gb-1462 Penile Cancer Treatment Market: Key Players Key companies operational in global penile cancer treatment market include Merck & Co., Inc., GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Novartis AG, and others.

  7. Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com Future Market Insights:616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 | D: +1-845-579-5705

More Related